Literature DB >> 18367860

[Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].

Su-Yeon Choi1, Donghee Kim, Jin Hwa Kang, Min Jung Park, Young Sun Kim, Seon Hee Lim, Chung Hyeon Kim, Hyo-Suk Lee.   

Abstract

BACKGROUND/AIMS: Non-alcoholic fatty liver disease (NAFLD) is closely associated with abdominal obesity, dyslipidemia, hypertension, and Type 2 diabetes, which are all features of the metabolic syndrome. The aim of the present study was to elucidate whether NAFLD is associated with carotid atherosclerosis.
METHODS: The study population comprised 659 subjects without hepatitis B and C infections and who did not consume alcohol. Fatty infiltrations of liver were detected by abdominal ultrasonography, and intima-media thickness (IMT) and plaque prevalence were estimated by carotid ultrasonography.
RESULTS: The mean values of systolic and diastolic pressures, body mass index (BMI), aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transpeptidase, uric acid, total cholesterol, triglycerides, high density lipoprotein (HDL) cholesterol, fasting glucose, fasting insulin, homeostasis model of assessment (HOMA) index, hemoglobin A1c, and plasminogen activator inhibitor-1 differed significantly between patients with NAFLD (n=314) and normal controls (n=345). The carotid IMT was 0.817+/-0.212 (mean+/-SD) mm in patients with NAFLD and 0.757+/-0.198 mm in normal controls (p<0.001). The prevalence of carotid plaques was higher in patients with NAFLD (26.4%) than in normal controls (15.9%) (p<0.001). This association persisted significantly after adjusting for age, sex, BMI, HOMA index and individual factors of metabolic syndrome by multiple logistic regression analysis.
CONCLUSIONS: Patients with NAFLD are at a high risk of carotid atherosclerosis regardless of metabolic syndrome and classical cardiovascular risk factors. Therefore, the detection of NAFLD should alert to the existence of an increased cardiovascular risk. Moreover, NAFLD might be an independent risk factor for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367860     DOI: 10.3350/kjhep.2008.14.1.77

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  19 in total

1.  Nonalcoholic fatty liver disease is associated with coronary artery calcification.

Authors:  Donghee Kim; Su-Yeon Choi; Eun Ha Park; Whal Lee; Jin Hwa Kang; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon; Sook Hyang Jeong; Dong Ho Lee; Hyo-suk Lee; Joseph Larson; Terry M Therneau; W Ray Kim
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

Review 2.  Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.

Authors:  Qing Pang; Jing-Yao Zhang; Si-Dong Song; Kai Qu; Xin-Sen Xu; Su-Shun Liu; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Ultrasound Diagnosis of Hepatic Steatosis as a Surrogate for Atherosclerosis.

Authors:  S Guth; E Windler; U Leise; C M Bamberger
Journal:  Ultrasound Int Open       Date:  2016-03-01

4.  Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans.

Authors:  Dae Hee Choi; Sung Joon Lee; Chang Don Kang; Myoung Ok Park; Dong Wook Choi; Tae Suk Kim; Wonho Lee; Byung Ryul Cho; Yong Hoon Kim; Bong-ki Lee; Dong Ryeol Ryu; Ji Won Lee
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

5.  Carotid lesions in outpatients with nonalcoholic fatty liver disease.

Authors:  Stefano Ramilli; Stefano Pretolani; Antonio Muscari; Barbara Pacelli; Vincenzo Arienti
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

6.  Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice.

Authors:  Amarnath Chatterjee; Hiroshi Kusunoki; Yoshiaki Taniyama; Hiromi Rakugi; Ryuichi Morishita
Journal:  Biomed Rep       Date:  2012-10-25

7.  Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Authors:  Hongyun Lu; Hong Liu; Fang Hu; Lingling Zou; Shunkui Luo; Liao Sun
Journal:  Int J Endocrinol       Date:  2013-04-10       Impact factor: 3.257

8.  Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis.

Authors:  Goh Eun Chung; Donghee Kim
Journal:  Clin Mol Hepatol       Date:  2013-06-27

9.  Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients.

Authors:  Ji Hoon Kang; Kyoung Im Cho; Seong Man Kim; Ja Young Lee; Jae Joon Kim; Ja Jun Goo; Kyoung Nyoun Kim; Joon Hyung Jhi; Dong Jun Kim; Hyeon Gook Lee; Tae Ik Kim
Journal:  J Cardiovasc Ultrasound       Date:  2012-09-21

10.  Relationship between Serum Aminotransferase Levels and Metabolic Disorders in Northern China.

Authors:  H Zhang; Yh Ding; Qm Li; J Sun; Sm He; Xw Feng; Yl Zhao; Xj Zhou; Yj Cai; C Wang; Xd Shi; Zf Wang; Q Zhou; Jq Niu
Journal:  Iran J Public Health       Date:  2012-02-29       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.